Prot #CL2-201086-002/GLPG1972-CL-201: Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with knee osteoarthritis. A 52-week international, multi-regional, multi-center, randomized, double-blind, placebo-controll

Project: Research project

StatusActive
Effective start/end date12/4/1812/4/21

Funding

  • Medpace Clinical Research LLC (Prot #CL2-201086-002/GLPG1972-CL-201)
  • Galapagos NV (Prot #CL2-201086-002/GLPG1972-CL-201)